The evolution of tumor metastases during clonal expansion

Journal of Theoretical Biology

Volumn 263, Issue 1, 2010, Pages 30-44

  Haeno, Hiroshi ^a,b   Michor, Franziska ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Branching processes; Cancer modeling; Stochastic dynamics

Indexed keywords

CANCER; CLONE; MORBIDITY; MORTALITY; NUMERICAL MODEL; PROBABILITY; STOCHASTICITY; TUMOR;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL COUNT; CLONING; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS; AUTOPSY; COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; PROBABILITY; STOCHASTIC PROCESSES; TREATMENT OUTCOME;

EID: 77649340937     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2009.11.005     Document Type: Article

References (31)

1. Bernards R., Weinberg R.A. A progression puzzle. Nature 2002, 418:823.
2. Bosl G.J., Geller N.L., Cirrincione C., CityVogelzang N.J., Kennedy B.J., Whitmore W.F., Vugrin D., Scher H., Nisselbaum J., Golbey R.B. Cancer Res. 1983, 43:3403-3407.
3. Cairns J. Mutation selection and the natural history of cancer. Nature 1975, 255:197-200.
4. Cazzaniga M.E., Dogliotti L., Cascinu S., Barni S., Labianca R., Chiara S., Conte P.F., Gasparini G., Pasetto L., Torri V. Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study. Oncology 2006, 71:281-374.
5. Dawson L.A., Chow E., Goss P.E. Evolving perspectives in contralateral breast cancer. Eur. J. Cancer 1998, 34:2000-2009.
6. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
7. Dingli D., Michor F., Antal T., Pacheco J.M. The emergence of tumor metastases. Cancer Biol. Ther. 2007, 6:383-390.
8. El Kamar F.G., Grossbard M.L., Kozuch P.S. Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care. The Oncologist 2003, 8:18-34.
9. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., Jeong J.-H., Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002, 347:1233-1241.
10. Haeno H., Iwasa Y., Michor F. The evolution of two mutations during clonal expansion. Genetics 2007, 177:2209-2221.
11. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
12. Hess K.R., Varadhachary G.R., CityplaceTaylor S.H., Raber M.N., Lenzi R., Abbruzzese J.L. Metastatic patterns in adenocarcinoma. Cancer 2006, 106:1624-1633.
13. Holyoake T., Jiang X., Eaves C., Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999, 94:2056-2064.
14. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmüller G., CityKlein C.A. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
15. Iwasa Y., Nowak M.A., Michor F. Evolution of resistance during clonal expansion. Genetics 2006, 172:2557-2566.
16. Jechlinger M., Sommer A., Moriggl R., Seither P., Kraut N., Capodiecci P., Donovan M., Cordon-Cardo C., Beug H., Grünert S. Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 2006, 116:1561-1570.
17. Michor F., Hughes T.P., Iwasa Y., Branford S., Shah N.P., Sawyers C.L., Nowak M.A. Dynamics of chronic myeloid leukemia. Nature 2005, 435:1267-1270.
18. Michor F., Nowak M.A., Iwasa Y. Stochastic dynamics of metastasis formation. J. Theor. Biol. 2006, 240:521-530.
19. Michor F., Iwasa Y. Dynamics of metastasis suppressor gene inactivation. J. Theor. Biol. 2006, 241:676-689.
20. Panetta J.C. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment. Bull. Math. Biol. 1996, 58:425-447.
21. Podsypanina K., Du Y.-C.N., Jechlinger M., Beverly L.J., Hambardzumyan D., Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321:1841-1844.
22. Pozzatti R., Muschel R., Williams J., Padmanabhan R., Howard B., Liotta L., Khoury G. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 1986, 232:223-227.
23. Riethdorf S., Wikman H., Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int. J. Cancer 2008, 123:1991-2006.
24. Roodman G.D. Mechanisms of bone metastasis. N. Engl. J. Med. 2004, 350:1655-1664.
25. Sahai E. Illuminating the metastasis process. Nat. Rev. Cancer 2007, 7:737-749.
26. placeThames H.D., Buchholz T.A., Smith C.D. Frequency of first metastatic events in breast cancer: implications for sequencing of systematic and local-regional treatment. J. Clin. Oncol. 1999, 17:2649-2658.
27. Wyllie A.H., Rose K.A., Morris R.G., Steel C.M., Foster E., Spandidos D.A. Rodent fibroblast tumors expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br. J. Cancer 1987, 56(3):251-259.
28. Yang J., CityMani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., CityplaceRichardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
29. Yoshida B.A., Dubauskas Z., Chekmareva M.A., Christiano T.R., Stadler W.M., Rinker-Schaeffer C.W. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 1999, 59:5483-5487.
30. Yoshida B.A., Sokoloff M.M., Welch D.R., Rinker-Schaeffer C.W. Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl. Cancer Inst. 2000, 92:1717-1730.
31. Yu D.H., Hung M.C. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3t3 cells. Oncogene 1991, 6:1991-1996.